Evolent Health EVH
Evolent Health, Inc. · NYSE · Services-Management Services
$3.90+13.70%close on Nov. 20, 2026 · volume 4.4M · Yahoo Finance
Price, last 64 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Aug. 26, 2026 | Daniel Joseph McCarthy PRESIDENT | Sold 10b5-1 plan | 65,892 | $5.00 | $329,460 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 8 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedEvolent Health Q3 2026 revenue of $725.4 million up 51% year over year, adjusted EPS $0.06 in line with consensus; Adjusted EBITDA guidance raised to $130.0-$135.0 million
Results of operations and financial condition · Financial statements and exhibits